Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors.
Hyo Jung ParkLei QinZiad BakounyKatherine M KrajewskiEliezer M Van AllenToni K ChoueiriAtul B ShinagarePublished in: The oncologist (2022)
CT texture analysis performed at baseline and early after starting PD-1/PD-L1 inhibitors is associated with clinical outcomes of patients with mRCC.